Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.

MLA

Finney, Lydia J., et al. “Inhaled Corticosteroids Downregulate the SARS-CoV-2 Receptor ACE2 in COPD through Suppression of Type I Interferon.” Journal of Allergy & Clinical Immunology, vol. 147, no. 2, Feb. 2021, p. 510. EBSCOhost, https://doi.org/10.1016/j.jaci.2020.09.034.

APA

Finney, L. J., Glanville, N., Farne, H., Aniscenko, J., Fenwick, P., Kemp, S. V., Trujillo-Torralbo, M.-B., Loo, S. L., Calderazzo, M. A., Wedzicha, J. A., Mallia, P., Bartlett, N. W., Johnston, S. L., & Singanayagam, A. (2021). Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. Journal of Allergy & Clinical Immunology, 147(2), 510. https://doi.org/10.1016/j.jaci.2020.09.034

Chicago

Finney, Lydia J., Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V. Kemp, Maria-Belen Trujillo-Torralbo, et al. 2021. “Inhaled Corticosteroids Downregulate the SARS-CoV-2 Receptor ACE2 in COPD through Suppression of Type I Interferon.” Journal of Allergy & Clinical Immunology 147 (2): 510. doi:10.1016/j.jaci.2020.09.034.